Prof. Stephan Nussberger, a co-author of the study, explains, "This means that we can use DNA nanorobots to design the shape and configuration of GUVs to enable the formation of transport channels in the membrane." Unlike biological cells, these nanorobots function without direct biological equivalents, making them versatile tools for synthetic biology.
The channels created by the DNA nanorobots facilitate the passage of therapeutic proteins into cells, with the ability to program their opening and closing. This system offers potential for improved delivery of medications and therapeutic enzymes. By mimicking the behavior of living cells, this approach opens new possibilities for disease research and drug delivery.
MEDICA-tradefair.com; Source: University of Stuttgart